Elevance Health, Inc. ELV
NYSE · XNYS · stock · Hospital & Medical Service Plans
Chart by TradingView
5/9
Piotroski F — financial health
3.13
Altman Z″ — distress risk · safe
27.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $199.1B | $5.7B | — | $3.2B | $43.9B |
| 2024 | $177.0B | $6.0B | — | $4.6B | $41.4B |
| 2023 | $171.3B | $6.0B | — | $6.8B | $39.4B |
| 2022 | $156.6B | $5.9B | — | $7.2B | $36.3B |
| 2021 | $138.6B | $6.2B | — | $7.3B | $36.1B |
| 2020 | $121.9B | $4.6B | — | $9.7B | $33.2B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Penczek Ronald W | CAO & Controller | 2026-06-12 | Sell | 369 | $403.16 |
| Dixon Robert L JR | director | 2026-06-11 | Sell | 151 | $401.77 |
| Penczek Ronald W | CAO & Controller | 2026-05-19 | Option exercise | 654 | $271.27 |
| Penczek Ronald W | CAO & Controller | 2026-05-19 | Option exercise | 877 | $311.48 |
| Penczek Ronald W | CAO & Controller | 2026-05-19 | Sell | 1,531 | $403.13 |
| STRABLE-SOETHOUT DEANNA D | director | 2026-05-13 | Grant | 563 | — |
| SCHULMAN AMY W | director | 2026-05-13 | Grant | 563 | — |
| Schneider Ryan M. | director | 2026-05-13 | Grant | 563 | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.13 (safe)
- Working capital / assets 0.181
- Retained earnings / assets 0.291
- EBIT / assets 0.059
- Equity / liabilities 0.566
Source: SEC EDGAR filings · CIK 0001156039 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.